Gerrit Draisma

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

Gerrit Draisma, Rob Boer, Suzie J. Otto et al. · JNCI Journal of the National Cancer Institute · 2003 · 1.1K citations · Full text

Medicine, Preventive Medicine, Urology +16

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

Gerrit Draisma, Ruth Etzioni, Alex Tsodikov et al. · JNCI Journal of the National Cancer Institute · 2009 · 794 citations · Full text

Medicine, Preventive Medicine, Urology +14

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

Jeanne S. Mandelblatt, Kathleen A. Cronin, Stephanie Bailey et al. · Annals of Internal Medicine · 2009 · 607 citations · Full text

Medicine, Population Health Sciences, Preventive Medicine +17

Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)

Carola A. van Iersel, Harry J. de Koning, Gerrit Draisma et al. · International Journal of Cancer · 2006 · 493 citations · Full text

Medicine, Biostatistics, Radiology +16

Quality-of-Life Effects of Prostate-Specific Antigen Screening

Eveline A.M. Heijnsdijk, Elisabeth M. Wever, Anssi Auvinen et al. · New England Journal of Medicine · 2012 · 425 citations · Full text

Medicine, Oncology, Urology +7